Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.31
Delayed Data
As of Dec 07
 -0.57 / -4.80%
Today’s Change
6.96
Today|||52-Week Range
17.78
-34.74%
Year-to-Date

Today’s Trading

Previous close11.88
Today’s open11.49
Day’s range10.99 - 11.57
Volume1,722,715
Average volume (3 months)1,520,540
Market cap$1.5B
Dividend yield--
Data as of 12/07/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-248.35%
Earnings growth (next 5 years)+47.05%
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book35.41

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-1.41-2.60%
EXASExact Sciences Corp0.000.00%
FPRXFive Prime Therapeut...-6.02-10.13%
ONCESpark Therapeutics I...-3.59-6.24%
Data as of 12/07/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts


Search for Jobs